amikacin has been researched along with Bacteroides Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bourquelot, P; Bouscary, D; Dreyfus, F; Paul, G; Picard, F; Tulliez, M; Varet, B | 1 |
Clément, C; Demingeon, G; Holzapfel, L; Madinier, G; Ohen, F; Villette, P | 1 |
2 other study(ies) available for amikacin and Bacteroides Infections
Article | Year |
---|---|
Hemophagocytic syndrome associated with Bacteroides fragilis infection in a patient with acute monoblastic leukemia.
Topics: Amikacin; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Ceftazidime; Cytarabine; Daunorubicin; Drug Therapy, Combination; Fatal Outcome; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Leukemia, Monocytic, Acute; Middle Aged; Moxalactam; Tonsillitis; Vancomycin | 1996 |
[Diffusion of amikacin into the sinuses in patients with nosocomial sinusitis. Administration of a single dose per day].
Topics: Adult; Aged; Amikacin; Bacteroides Infections; Cross Infection; Diffusion; Dose-Response Relationship, Drug; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Injections, Intravenous; Male; Middle Aged; Paranasal Sinuses; Sinusitis; Streptococcal Infections | 1992 |